Ցելեստոդերմ-Վ

Հիմնական տեղեկություններ

  • Ֆիրմային անվանումը:
  • Ցելեստոդերմ-Վ
  • Դոզան:
  • 1մգ/գ
  • Դեղագործական ձեւ:
  • քսուք
  • Միավորները փաթեթում:
  • 30գ ալյումինե պարկուճ
  • Ռեկվիզորի տեսակը:
  • Դեղատոմսով
  • Բժշկության տիրույթում:
  • Մարդիկ
  • Բժշկության տեսակ:
  • Ալլոպատիկ դեղամիջոց
  • Պատրաստված է:
  • Շերինգ-Պլաու Լաբո Ն.Վ.

Փաստաթղթեր

  • Հանրության համար:
  • Այս ապրանքի տեղեկատվական թերթիկը ներկայումս մատչելի չէ, դուք կարող եք խնդրանքը ուղարկել մեր հաճախորդների սպասարկմանը եւ մենք կտեղեկացնենք այն ժամանակ, երբ մենք կարող ենք ձեռք բերել այն:


    Տեղեկատվության թերթիկից պահանջել հանրությանը:

Տեղայնացումը

  • Հասանելի է:
  • Ցելեստոդերմ-Վ
    አርሜኒያ
  • Լեզու:
  • አማርኛ

Այլ տեղեկություններ

Կարգավիճակը

  • Աղբյուրը:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • Վերջին թարմացումը:
  • 09-08-2016
  • Այս ապրանքի տեղեկատվական թերթիկը ներկայումս մատչելի չէ, դուք կարող եք խնդրանքը ուղարկել մեր հաճախորդների սպասարկմանը եւ մենք կտեղեկացնենք այն ժամանակ, երբ մենք կարող ենք ձեռք բերել այն:

    Տեղեկատվության թերթիկից պահանջել հանրությանը:

  • Այս փաստաթուղթը հասանելի է միայն գրանցված օգտագործողների համար:

    Register now for full access

2-5-2018

April 17, 2018: Tampa Resident Sentenced to More Than 20 Years in Federal Prison for Tricare Health Care Fraud Scheme

April 17, 2018: Tampa Resident Sentenced to More Than 20 Years in Federal Prison for Tricare Health Care Fraud Scheme

April 17, 2018: Tampa Resident Sentenced to More Than 20 Years in Federal Prison for Tricare Health Care Fraud Scheme

FDA - U.S. Food and Drug Administration

21-5-2018

EU/3/17/1945 (MN Development AB)

EU/3/17/1945 (MN Development AB)

EU/3/17/1945 (Active substance: Tiratricol) - Transfer of orphan designation - Commission Decision (2018)3135 of Mon, 21 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/128/17/T/01

Europe -DG Health and Food Safety

18-5-2018

EU/3/17/1936 (Pharma Gateway AB)

EU/3/17/1936 (Pharma Gateway AB)

EU/3/17/1936 (Active substance: 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea) - Transfer of orphan designation - Commission Decision (2018)3133 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/119/17/T/01

Europe -DG Health and Food Safety

17-5-2018

#ThrowBackThursday: May 17, 1971- The Public Health Service Bureau of Radiological Health transferred to FDA. It’s Mission: Protect against unnecessary human exposure to radiation from electronic products in the home and industry. #OnThisDay #FDAHistory

#ThrowBackThursday: May 17, 1971- The Public Health Service Bureau of Radiological Health transferred to FDA. It’s Mission: Protect against unnecessary human exposure to radiation from electronic products in the home and industry. #OnThisDay #FDAHistory

#ThrowBackThursday: May 17, 1971- The Public Health Service Bureau of Radiological Health transferred to FDA. It’s Mission: Protect against unnecessary human exposure to radiation from electronic products in the home and industry. #OnThisDay #FDAHistory

FDA - U.S. Food and Drug Administration

16-5-2018

EU/3/17/1919 (Roche Registration GmbH)

EU/3/17/1919 (Roche Registration GmbH)

EU/3/17/1919 (Active substance: Bitopertin) - Transfer of orphan designation - Commission Decision (2018)3030 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/112/17/T/01

Europe -DG Health and Food Safety

16-5-2018

EU/3/17/1954 (AbbVie Deutschland GmbH and Co. KG)

EU/3/17/1954 (AbbVie Deutschland GmbH and Co. KG)

EU/3/17/1954 (Active substance: Venetoclax) - Transfer of orphan designation - Commission Decision (2018)3028 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/131/17/T/01

Europe -DG Health and Food Safety

18-4-2018

Health Tip: Understanding Allergy Blood Testing

Health Tip: Understanding Allergy Blood Testing

Title: Health Tip: Understanding Allergy Blood TestingCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Health Tip: If You're Pregnant and Have Diabetes

Health Tip: If You're Pregnant and Have Diabetes

Title: Health Tip: If You're Pregnant and Have DiabetesCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Organs From Opioid OD Victims Are Saving Lives: Study

Organs From Opioid OD Victims Are Saving Lives: Study

Title: Organs From Opioid OD Victims Are Saving Lives: StudyCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Go Nuts for Heart Health

Go Nuts for Heart Health

Title: Go Nuts for Heart HealthCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Can Mom-to Be's' Weight Affect Daughters' Risk for Early Puberty?

Can Mom-to Be's' Weight Affect Daughters' Risk for Early Puberty?

Title: Can Mom-to Be's' Weight Affect Daughters' Risk for Early Puberty?Category: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

'Flexitarian' Eating: Part Vegetarian, Part Not

'Flexitarian' Eating: Part Vegetarian, Part Not

Title: 'Flexitarian' Eating: Part Vegetarian, Part NotCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Sen. John McCain Recovering After Intestinal Surgery

Sen. John McCain Recovering After Intestinal Surgery

Title: Sen. John McCain Recovering After Intestinal SurgeryCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

17-4-2018

Autologous skeletal myoblasts expanded ex vivo (Assistance Publique - Hopitaux de Paris (APHP))

Autologous skeletal myoblasts expanded ex vivo (Assistance Publique - Hopitaux de Paris (APHP))

Autologous skeletal myoblasts expanded ex vivo (Active substance: Autologous skeletal myoblasts expanded ex vivo) - Refusal of orphan designation - Commission Decision (2018)2354 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/144/17

Europe -DG Health and Food Safety

28-3-2018

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (Active substance: Sodium (1R,3R,4R,5S)-3-({2-N-acetylamino-2-deoxy-3-O-[(1S)-1-carboxylato-2-cyclohexylethyl]-beta-D-galactopyranosyl}oxy)-4-({6-deoxy-alpha-L-galactopyranosyl}oxy)-5-ethyl-cyclohexan-1-yl-(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carboxamide) - Transfer of orphan designation - Commission Decision (2018)2011 of Wed, 28 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/010/17/T/01

Europe -DG Health and Food Safety

22-3-2018

BETAMETHASONE VALERATE Cream [Preferred Pharmaceuticals, Inc.]

BETAMETHASONE VALERATE Cream [Preferred Pharmaceuticals, Inc.]

Updated Date: Mar 22, 2018 EST

US - DailyMed

21-3-2018

EU/3/17/1861 (Roivant Sciences Ireland Limited)

EU/3/17/1861 (Roivant Sciences Ireland Limited)

EU/3/17/1861 (Active substance: (S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester) - Transfer of orphan designation - Commission Decision (2018)1826 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/299/16/T/01

Europe -DG Health and Food Safety

13-2-2018

BETAMETHASONE VALERATE Ointment [Preferred Pharmaceuticals Inc.]

BETAMETHASONE VALERATE Ointment [Preferred Pharmaceuticals Inc.]

Updated Date: Feb 13, 2018 EST

US - DailyMed

12-2-2018

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications

Title: Rheumatoid Arthritis (RA): 17 Warning Signs of Serious ComplicationsCategory: Doctor's & Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM

US - MedicineNet

24-1-2018

EU/3/17/1971 (Edison Orphan Pharma BV)

EU/3/17/1971 (Edison Orphan Pharma BV)

EU/3/17/1971 (Active substance: Vatiquinone) - Orphan designation - Commission Decision (2018)393 of Wed, 24 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/145/17

Europe -DG Health and Food Safety

20-1-2018

EU/3/17/1965 (Duchenne UK)

EU/3/17/1965 (Duchenne UK)

EU/3/17/1965 (Active substance: Metformin and L-citrulline) - Orphan designation - Commission Decision (2018)387 of Sat, 20 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/154/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1958 (Voisin Consulting S.A.R.L.)

EU/3/17/1958 (Voisin Consulting S.A.R.L.)

EU/3/17/1958 (Active substance: Allogeneic umbilical cord blood CD34+ cells cultured ex vivo with Notch ligand Delta1) - Orphan designation - Commission Decision (2018)379 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/192/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1970 (Rare Partners srl Impresa Sociale)

EU/3/17/1970 (Rare Partners srl Impresa Sociale)

EU/3/17/1970 (Active substance: Sirolimus) - Orphan designation - Commission Decision (2018)392 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/184/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1967 (Millendo Therapeutics Ltd)

EU/3/17/1967 (Millendo Therapeutics Ltd)

EU/3/17/1967 (Active substance: N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt) - Orphan designation - Commission Decision (2018)389 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/179/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1957 (uniQure Biopharma B.V.)

EU/3/17/1957 (uniQure Biopharma B.V.)

EU/3/17/1957 (Active substance: Adeno-associated viral vector serotype 5 encoding a microRNA targeted to human huntingtin gene) - Orphan designation - Commission Decision (2018)378 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/151/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1956 (Quintiles Ireland Limited)

EU/3/17/1956 (Quintiles Ireland Limited)

EU/3/17/1956 (Active substance: Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human iduronate 2-sulfatase gene) - Orphan designation - Commission Decision (2018)377 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/168/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1955 (Quintiles Ireland Limited)

EU/3/17/1955 (Quintiles Ireland Limited)

EU/3/17/1955 (Active substance: Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene) - Orphan designation - Commission Decision (2018)376 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/167/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1966 (Sirius Regulatory Consulting Limited)

EU/3/17/1966 (Sirius Regulatory Consulting Limited)

EU/3/17/1966 (Active substance: N-(bromoacetyl)-3,3-dinitroazetidine) - Orphan designation - Commission Decision (2018)388 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/166/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1964 (Incyte Biosciences UK Ltd)

EU/3/17/1964 (Incyte Biosciences UK Ltd)

EU/3/17/1964 (Active substance: Itacitinib) - Orphan designation - Commission Decision (2018)385 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/169/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1963 (Professor Pascale De Lonlay)

EU/3/17/1963 (Professor Pascale De Lonlay)

EU/3/17/1963 (Active substance: Hydroxychloroquine sulphate) - Orphan designation - Commission Decision (2018)384 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/177/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1962 (MWB Consulting Ltd)

EU/3/17/1962 (MWB Consulting Ltd)

EU/3/17/1962 (Active substance: Humanised Fc-engineered monoclonal antibody against CD19) - Orphan designation - Commission Decision (2018)383 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/155/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1961 (Astellas Pharma Europe B.V.)

EU/3/17/1961 (Astellas Pharma Europe B.V.)

EU/3/17/1961 (Active substance: Gilteritinib) - Orphan designation - Commission Decision (2018)382 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/175/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1960 (Atlas Molecular Pharma S.L.)

EU/3/17/1960 (Atlas Molecular Pharma S.L.)

EU/3/17/1960 (Active substance: Ciclopirox) - Orphan designation - Commission Decision (2018)381 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/186/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1959 (GW Research Ltd)

EU/3/17/1959 (GW Research Ltd)

EU/3/17/1959 (Active substance: Cannabidiol) - Orphan designation - Commission Decision (2018)380 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/165/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1969 (University of Cambridge)

EU/3/17/1969 (University of Cambridge)

EU/3/17/1969 (Active substance: Recombinant adeno-associated viral vector serotype 2/1 encoding human beta-hexosaminidase alpha and beta subunits) - Orphan designation - Commission Decision (2018)391 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/182/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1968 (Regintel Limited)

EU/3/17/1968 (Regintel Limited)

EU/3/17/1968 (Active substance: Pyrazolo[1,5-a]pyrimidine, 3-[4-chloro-2-(4-morpholinyl)-5-thiazolyl]-7-(1-ethylpropyl)-2,5-dimethyl-pyrazolo[1,3-a]pyrimidine) - Orphan designation - Commission Decision (2018)390 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/164/17

Europe -DG Health and Food Safety

18-1-2018

Health Tip: Is Your Food Still Good After Power Outage?

Health Tip: Is Your Food Still Good After Power Outage?

Title: Health Tip: Is Your Food Still Good After Power Outage?Category: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Health Tip: If You're Stuck Inside During a Winter Storm

Health Tip: If You're Stuck Inside During a Winter Storm

Title: Health Tip: If You're Stuck Inside During a Winter StormCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Creativity May Rely on 'Teamwork' in the Brain

Creativity May Rely on 'Teamwork' in the Brain

Title: Creativity May Rely on 'Teamwork' in the BrainCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Sleep Better, Lose Weight?

Sleep Better, Lose Weight?

Title: Sleep Better, Lose Weight?Category: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Don't Rely on Just One Blood Pressure Test for Kids: Study

Don't Rely on Just One Blood Pressure Test for Kids: Study

Title: Don't Rely on Just One Blood Pressure Test for Kids: StudyCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

The Second Stage of Diet Resolutions

The Second Stage of Diet Resolutions

Title: The Second Stage of Diet ResolutionsCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Salmonella Outbreak Linked to Coconut Tree Brand Frozen Shredded Coconut

Salmonella Outbreak Linked to Coconut Tree Brand Frozen Shredded Coconut

Title: Salmonella Outbreak Linked to Coconut Tree Brand Frozen Shredded CoconutCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

15-12-2017

EU/3/17/1950 (MeiraGTx UK II Limited)

EU/3/17/1950 (MeiraGTx UK II Limited)

EU/3/17/1950 (Active substance: Adenovirus associated viral vector serotype 8 containing the human AIPL1 gene) - Orphan designation - Commission Decision (2017)8782 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/162/17

Europe -DG Health and Food Safety

15-12-2017

EU/3/17/1954 (AbbVie Ltd)

EU/3/17/1954 (AbbVie Ltd)

EU/3/17/1954 (Active substance: Venetoclax) - Orphan designation - Commission Decision (2017)8786 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/131/17

Europe -DG Health and Food Safety

15-12-2017

EU/3/17/1951 (Clinical Network Services (UK) Ltd)

EU/3/17/1951 (Clinical Network Services (UK) Ltd)

EU/3/17/1951 (Active substance: Agammaglobulinaemia tyrosine kinase) - Orphan designation - Commission Decision (2017)8783 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/157/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1952 (PhaseRx Ireland, Ltd)

EU/3/17/1952 (PhaseRx Ireland, Ltd)

EU/3/17/1952 (Active substance: Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles) - Orphan designation - Commission Decision (2017)8784 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/153/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1953 (Protalix B.V)

EU/3/17/1953 (Protalix B.V)

EU/3/17/1953 (Active substance: Pegunigalsidase alfa) - Orphan designation - Commission Decision (2017)8785 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/138/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1949 (IntraBio Ltd)

EU/3/17/1949 (IntraBio Ltd)

EU/3/17/1949 (Active substance: Acetylleucine) - Orphan designation - Commission Decision (2017)8781 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/158/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1948 (Premier Research Group Limited)

EU/3/17/1948 (Premier Research Group Limited)

EU/3/17/1948 (Active substance: 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl) - Orphan designation - Commission Decision (2017)8780 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/135/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1947 (NeuroVive Pharmaceutical AB)

EU/3/17/1947 (NeuroVive Pharmaceutical AB)

EU/3/17/1947 (Active substance: 2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione) - Orphan designation - Commission Decision (2017)8779 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/132/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1946 (FGK Representative Service GmbH)

EU/3/17/1946 (FGK Representative Service GmbH)

EU/3/17/1946 (Active substance: (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidine-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridine-2-yl)-4-fluoropyrrolidine-2-carboxamide) - Orphan designation - Commission Decision (2017)8778 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/156/17

Europe -DG Health and Food Safety

7-12-2017

BETAMETHASONE VALERATE Ointment [Proficient Rx LP]

BETAMETHASONE VALERATE Ointment [Proficient Rx LP]

Updated Date: Dec 7, 2017 EST

US - DailyMed

17-11-2017

Lemtrada (Genzyme Therapeutics Ltd)

Lemtrada (Genzyme Therapeutics Ltd)

Lemtrada (Active substance: Alemtuzumab) - Centralised - 2-Monthly update - Commission Decision (2017) 7765 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/3718/II/17

Europe -DG Health and Food Safety

17-11-2017

Dr. Tommy John Hopes Fewer Young Athletes Need Dad's Namesake Surgery

Dr. Tommy John Hopes Fewer Young Athletes Need Dad's Namesake Surgery

Title: Dr. Tommy John Hopes Fewer Young Athletes Need Dad's Namesake SurgeryCategory: Health NewsCreated: 11/17/2017 12:00:00 AMLast Editorial Review: 11/17/2017 12:00:00 AM

US - MedicineNet

17-11-2017

5 Tasty Diet Desserts

5 Tasty Diet Desserts

Title: 5 Tasty Diet DessertsCategory: Health NewsCreated: 11/17/2017 12:00:00 AMLast Editorial Review: 11/17/2017 12:00:00 AM

US - MedicineNet

14-11-2017

EU/3/17/1835 (Abeona Therapeutics Europe SL)

EU/3/17/1835 (Abeona Therapeutics Europe SL)

EU/3/17/1835 (Active substance: Ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the COL7A1 gene) - Transfer of orphan designation - Commission Decision (2017)7626 of Tue, 14 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/283/16/T/01

Europe -DG Health and Food Safety

14-11-2017

BETA 1 KIT (Betamethasone Sodium Phosphate, Betamethasone Acetate) Kit [Oaklock, LLC]

BETA 1 KIT (Betamethasone Sodium Phosphate, Betamethasone Acetate) Kit [Oaklock, LLC]

Updated Date: Nov 14, 2017 EST

US - DailyMed

10-11-2017

EU/3/17/1933 (Quintiles Ireland Limited)

EU/3/17/1933 (Quintiles Ireland Limited)

EU/3/17/1933 (Active substance: (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione) - Orphan designation - Commission Decision (2017)7555 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/142/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1935 (Edvince AB)

EU/3/17/1935 (Edvince AB)

EU/3/17/1935 (Active substance: 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) - Orphan designation - Commission Decision (2017)7557 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/120/17

Europe -DG Health and Food Safety